rwilkins on PROD1PC63 with NOTICES

75258 Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS 

Respondents Number of respondents 

Average number of responses per 

respondent 

Average burden per response 

(in hours) 

Total burden 

(in hours) 

Clerical and hospital staff of state and local health department STD project 

areas ............................................................................................................ 50 

(electronic 

data) 

15 

(hardcopy 

data) 

8 

8 

15/60 

30/60 

100 

60 

Dated: December 7, 2006. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E6–21273 Filed 12–13–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Mine Safety and Health Research 

Advisory Committee: Notice of Charter 

Renewal 

This gives notice under the Federal 

Advisory Committee Act (Public Law 

92–463) of October 6, 1972, that the 

Mine Safety and Health Research 

Advisory Committee, Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services, has been renewed for a 2-year 

period through November 30, 2008. 

For information, contact Jeffrey 

Kohler, Ph.D., Executive Secretary, 

Mine Safety and Health Research 

Advisory Committee, Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services, 626 Cochrans Mill Road, 

Mailstop P05, Pittsburgh, Pennsylvania 

15236, telephone 412/386–5301 or fax 

404/386–5300. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 8, 2006. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E6–21264 Filed 12–13–06; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Decision To Evaluate a Petition To 

Designate a Class of Employees at 

Dow Chemical Company, Madison, IL, 

To Be Included in the Special 

Exposure Cohort 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice as 

required by 42 CFR § 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees at Dow 

Chemical Company, Madison, Illinois, 

to be included in the Special Exposure 

Cohort under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Dow Chemical Company. 

Location: Madison, Illinois. 

Job Titles and/or Job Duties: All 

Atomic Weapons Employer employees 

who were monitored, or should have 

been monitored, for exposure to 

ionizing radiation while working for a 

number of work days aggregating at least 

250 work days, either solely under this 

employment or in combination with 

work days within the parameters 

established for one or more other classes 

of employees in the Special Exposure 

Cohort. 

Period of Employment: January 1, 

1957 through December 21, 1960. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV. 

Dated: December 7, 2006. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 06–9668 Filed 12–13–06; 8:45 am] 

BILLING CODE 4163–19–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 


Public Health Service, HHS. 


ACTION: Notice. 


SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of federally 

funded research and development. 

Foreign patent applications are filed on 

selected inventions to extend market 

coverage for companies and may also be 

available for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Peptide and Peptidomimetic Inhibitors 

of Smoothened Protein as Antineoplastic Agents 

Description of Technology: Cancer is 

caused by the improper regulation of 

certain signaling proteins in the cell.